ABO mismatch is associated with increased non-relapse mortality after allogeneic hematopoietic cell transplantation

We evaluated ABO associated outcomes in 1,737 patients who underwent allogeneic hematopoietic cell transplant (allo-HCT) at Stanford University between January 1986 and July 2011. Grafts were 61% ABO matched, 18% major mismatched (MM), 17% minor MM, and 4% bidirectional MM. Median follow-up was 6 ye...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biol Blood Marrow Transplant
Autors principals: Logan, Aaron C., Wang, Zhiyu, Alimoghaddam, Kamran, Wong, Ruby M., Lai, Tze, Negrin, Robert S., Grumet, Carl, Logan, Brent R., Zhang, Mei-Jie, Spellman, Stephen R., Lee, Stephanie J., Miklos, David B.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4363312/
https://ncbi.nlm.nih.gov/pubmed/25572032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.12.036
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars